Search results
Results from the WOW.Com Content Network
EC 3.2.1.3 : is a digestive enzyme Cellulase # EC 3.2.1.4 : breaks down cellulose from plant material Sucrase-isomaltase: EC 3.2.1.10 - Mannosyl-oligosaccharide glucosidase # EC 3.2.1.106 catalyzes the first trimming step of the N-glycosylation pathway; is associated with Congenital Disorder of Glycosylation type IIb: Acid α-glucosidase # EC 3 ...
α-Glucosidase hydrolyzes terminal non-reducing (1→4)-linked α-glucose residues to release a single α-glucose molecule. [ 10 ] α-Glucosidase is a carbohydrate-hydrolase that releases α-glucose as opposed to β-glucose. β-Glucose residues can be released by glucoamylase, a functionally similar enzyme.
Alglucosidase alfa is indicated for people with Pompe disease (GAA deficiency). [1]In 2014 the U.S. Food and Drug Administration announced the approval of alglucosidase alfa for treatment of people with infantile-onset Pompe disease, including people who are less than eight years of age.
Acid alpha-glucosidase, also called acid maltase, [5] is an enzyme that helps to break down glycogen in the lysosome. It is functionally similar to glycogen debranching enzyme , but is on a different chromosome, processed differently by the cell and is located in the lysosome rather than the cytosol. [ 6 ]
76051 Ensembl ENSG00000214013 ENSMUSG00000062646 UniProt Q8TET4 Q8BVW0 RefSeq (mRNA) NM_198141 NM_001301409 NM_001301410 NM_172672 RefSeq (protein) NP_001288338 NP_001288339 NP_937784 NP_766260 Location (UCSC) Chr 15: 42.27 – 42.36 Mb Chr 2: 120.23 – 120.29 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Neutral alpha-glucosidase C is an enzyme that in humans is encoded by the ...
The most significant oligosaccharide β-glucosidase reacts with is cellulose. Cellulose is a polymer composed of β-1,4-linked glucosyl residues. β-glucosidases, cellulases (endoglucanases), cellobiosidases (exoglucanases) are required by a number of organisms to consume it. These enzymes are powerful tools for degradation of plant cell walls ...
[4] [5] Cipaglucosidase alfa is a recombinant human acid α-glucosidase enzyme replacement therapy that provides an exogenous source of acid α-glucosidase. [ 5 ] The most common side effects include chills, dizziness, flushing, sleepiness, chest discomfort, cough, swelling at the infusion site and pain. [ 5 ]
Glucan 1,4-α-glucosidase (EC 3.2.1.3, glucoamylase, amyloglucosidase, γ-amylase, lysosomal α-glucosidase, acid maltase, exo-1,4-α-glucosidase, glucose amylase, γ-1,4-glucan glucohydrolase, acid maltase, 1,4-α-D-glucan glucohydrolase) is an enzyme located on the brush border of the small intestine with systematic name 4-α-D-glucan glucohydrolase.